Extent:
XVI, 265 S.
graph. Darst.
cm
Series:
Type of publication: Book / Working Paper
Type of publication (narrower categories): Sammelwerk ; Collection of articles of several authors ; Fallstudie ; Case study
Language: English
Notes:
Enth. 13 Beitr.
Literaturangaben
Machine generated contents note:1. The New Political Economy of Pharmaceuticals: Conformity and Resistance in the Global South; Owain David Williams and Hans Löfgren -- 2. The Political Economy of Pharmaceutical Production in Brazil; Cassandra M. Sweet -- 3. Pharmaceuticals, Health Policy and Intellectual Property Rights in China; Chee-Ruey Hsieh -- 4. Immunity to TRIPS? Vaccine Production and the Biotechnology Industry in Cuba; Jens Plahte and Simon Reid-Henry -- 5. TRIPS and Access to Medicines in Egypt; Dina Iskander -- 6. The Pharmaceutical Industry in India after TRIPS; Sudip Chaudhuri -- 7. The Health Care System and the Pharmaceutical Industry in Indonesia; Richard Husada and Raymond R. Tjandrawinata -- 8. TRIPS, Free Trade Agreements and the Pharmaceutical Industry in Malaysia; Mohamed Azmi Hassali, Jayabalan Thambyappa, Shankaran Nambiar and Asrul Akmal Shafie -- 9. The Pharmaceutical Industry, Intellectual Property Rights and Access to Medicines in Pakistan: Zaheer-Ud-Din Babar, Shazia Jamshed, Ashar Malik and Anwarul-Hassan Gilani -- 10. TRIPS, Access to Medicines and Local Production in South Africa; Andrew L. Gray and Yousuf A. Vawda -- 11. TRIPS and New Challenges for the Pharmaceutical Sector in South Korea; Bong-min Yang and Hye-young Kwon -- 12. Intellectual Property Rights and Neoliberal Restructuring in Turkey: The Pharmaceutical Industry; Ipek Eren Vural -- 13. Conclusion: TRIPS, Drug Production in the Global South, and Access to Medicines; Hans Löfgren and Owain David Williams.
Machine generated contents note: -- 1. The New Political Economy of Pharmaceuticals: Conformity and Resistance in the Global South; Owain David Williams and Hans Löfgren -- 2. The Political Economy of Pharmaceutical Production in Brazil; Cassandra M. Sweet -- 3. Pharmaceuticals, Health Policy and Intellectual Property Rights in China; Chee-Ruey Hsieh -- 4. Immunity to TRIPS? Vaccine Production and the Biotechnology Industry in Cuba; Jens Plahte and Simon Reid-Henry -- 5. TRIPS and Access to Medicines in Egypt; Dina Iskander -- 6. The Pharmaceutical Industry in India after TRIPS; Sudip Chaudhuri -- 7. The Health Care System and the Pharmaceutical Industry in Indonesia; Richard Husada and Raymond R. Tjandrawinata -- 8. TRIPS, Free Trade Agreements and the Pharmaceutical Industry in Malaysia; Mohamed Azmi Hassali, Jayabalan Thambyappa, Shankaran Nambiar and Asrul Akmal Shafie -- 9. The Pharmaceutical Industry, Intellectual Property Rights and Access to Medicines in Pakistan: Zaheer-Ud-Din Babar, Shazia Jamshed, Ashar Malik and Anwarul-Hassan Gilani -- 10. TRIPS, Access to Medicines and Local Production in South Africa; Andrew L. Gray and Yousuf A. Vawda -- 11. TRIPS and New Challenges for the Pharmaceutical Sector in South Korea; Bong-min Yang and Hye-young Kwon -- 12. Intellectual Property Rights and Neoliberal Restructuring in Turkey: The Pharmaceutical Industry; Ipek Eren Vural -- 13. Conclusion: TRIPS, Drug Production in the Global South, and Access to Medicines; Hans Löfgren and Owain David Williams.
ISBN: 0-230-28463-9 ; 978-0-230-28463-0
Classification: Pharmazie, Pharmazeutika ; Gesundheitsökonomie ; Patentwesen, Erfindungen ; Gewerblicher Rechtsschutz, Verlagsrecht
Source:
ECONIS - Online Catalogue of the ZBW
Persistent link: https://www.econbiz.de/10009793209